UPDATE: Intellia Therapeutics (NTLA) PT Lowered to $83 at Morgan Stanley (correction)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to UPDATE: Intellia Therapeutics (NTLA) PT Lowered to $83 at Morgan Stanley (correction)

Intellia Therapeutics (NTLA) PT Lowered to $53 at Wedbush

November 3, 2022 11:36 AM EDT

Wedbush analyst David Nierengarten lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $53.00 (from $58.00) while maintaining a Neutral rating.... More

Intellia Therapeutics (NTLA) Misses Q3 EPS by 20c

November 3, 2022 7:36 AM EDT

Intellia Therapeutics (NASDAQ: NTLA) reported Q3 EPS of ($1.49), $0.20 worse than the analyst estimate of ($1.29). Revenue for the quarter came in at $13.27 million versus the consensus estimate of $11.43 million.

For earnings history and earnings-related data on Intellia Therapeutics (NTLA) click here.

... More